Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma
- 1 February 1997
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 33 (2), 220-225
- https://doi.org/10.1016/s0959-8049(96)00297-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 861 Treatment of advanced soft tissue sarcomas (STS) with high dose epirubicin (HD-EPI)European Journal Of Cancer, 1995
- Epirubicin and Ifosfamide in Advanced Soft Tissue Sarcoma: A Phase II StudyCancer Investigation, 1993
- Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomasAnnals Of Oncology, 1992
- Epirubicin and DTIC (EDIC) for Advanced Soft-Tissue SarcomasOncology, 1991
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- Cisplatin. A phase II evaluation in previously untreated patients with soft tissue sarcomasCancer, 1987
- Polychemotherapie fortgeschrittener Weichteilsarkome mit 4’-Epi-Doxorubicin (4’-Epi-DX) und Cisplatin (DDP)Oncology Research and Treatment, 1986
- Reporting results of cancer treatmentCancer, 1981
- Chemotherapy of advanced soft-tissue sarcomas in adultsCancer Treatment Reviews, 1977